Free Trial

This company has been marked as potentially delisted and may not be actively trading.

HealthCor Catalio Acquisition (HCAQ) Competitors

HCAQ vs. CHEK, GEHC, PHG, HOLX, BFLY, NNOX, AKYA, ARTV, TELA, and CTSO

Should you be buying HealthCor Catalio Acquisition stock or one of its competitors? The main competitors of HealthCor Catalio Acquisition include Check-Cap (CHEK), GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Hologic (HOLX), Butterfly Network (BFLY), Nano-X Imaging (NNOX), Akoya Biosciences (AKYA), Artiva Biotherapeutics (ARTV), TELA Bio (TELA), and Cytosorbents (CTSO).

HealthCor Catalio Acquisition vs.

HealthCor Catalio Acquisition (NASDAQ:HCAQ) and Check-Cap (NASDAQ:CHEK) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, community ranking, media sentiment, institutional ownership, risk, profitability, analyst recommendations and dividends.

Company Net Margins Return on Equity Return on Assets
HealthCor Catalio AcquisitionN/A N/A N/A
Check-Cap N/A N/A N/A

Check-Cap received 370 more outperform votes than HealthCor Catalio Acquisition when rated by MarketBeat users.

CompanyUnderperformOutperform
HealthCor Catalio AcquisitionN/AN/A
Check-CapOutperform Votes
370
60.76%
Underperform Votes
239
39.24%

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HealthCor Catalio AcquisitionN/AN/AN/AN/AN/A
Check-CapN/AN/A-$17.57M-$3.00-0.28

In the previous week, Check-Cap had 2 more articles in the media than HealthCor Catalio Acquisition. MarketBeat recorded 2 mentions for Check-Cap and 0 mentions for HealthCor Catalio Acquisition. HealthCor Catalio Acquisition's average media sentiment score of 0.00 beat Check-Cap's score of -0.72 indicating that HealthCor Catalio Acquisition is being referred to more favorably in the media.

Company Overall Sentiment
HealthCor Catalio Acquisition Neutral
Check-Cap Negative

84.2% of HealthCor Catalio Acquisition shares are held by institutional investors. Comparatively, 1.1% of Check-Cap shares are held by institutional investors. 0.5% of Check-Cap shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Check-Cap beats HealthCor Catalio Acquisition on 3 of the 5 factors compared between the two stocks.

Get HealthCor Catalio Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for HCAQ and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HCAQ vs. The Competition

MetricHealthCor Catalio AcquisitionX IndustryMedical SectorNASDAQ Exchange
Market Cap$11.61M$11.50B$5.39B$8.47B
Dividend YieldN/A1.73%5.28%4.16%
P/E RatioN/A18.0327.1319.87
Price / SalesN/A7.90392.64138.94
Price / CashN/A11.9038.3234.64
Price / BookN/A2.086.764.56
Net IncomeN/A$344.53M$3.23B$248.06M

HealthCor Catalio Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HCAQ
HealthCor Catalio Acquisition
N/A$0.54
-5.7%
N/A-38.0%$11.61MN/A0.002High Trading Volume
CHEK
Check-Cap
0.6708 of 5 stars
$0.89
+1.5%
N/A-62.7%$5.23MN/A-0.3080Gap Down
GEHC
GE HealthCare Technologies
4.2564 of 5 stars
$71.85
-1.7%
$88.27
+22.9%
-13.4%$32.90B$19.80B16.5950,000Positive News
PHG
Koninklijke Philips
2.1413 of 5 stars
$23.95
+0.3%
N/A-16.4%$22.51B$17.98B-28.5178,200Gap Up
HOLX
Hologic
4.8579 of 5 stars
$56.47
+0.1%
$77.42
+37.1%
-26.4%$12.58B$4.03B17.816,940Positive News
Analyst Forecast
Trading Halted
BFLY
Butterfly Network
2.4483 of 5 stars
$2.29
-1.3%
$4.00
+74.7%
+115.8%$566.29M$85.63M-4.98460Gap Up
NNOX
Nano-X Imaging
1.364 of 5 stars
$5.49
+0.2%
$12.00
+118.6%
-39.1%$317.21M$11.28M-6.46190Earnings Report
Gap Down
AKYA
Akoya Biosciences
1.2401 of 5 stars
$1.06
+1.0%
$2.51
+136.4%
-35.9%$52.87M$79.96M-0.9090
ARTV
Artiva Biotherapeutics
1.5527 of 5 stars
$2.16
+6.9%
$19.40
+798.1%
N/A$52.62M$251,000.000.0081
TELA
TELA Bio
1.9692 of 5 stars
$1.33
+15.7%
$7.25
+445.1%
-75.4%$52.61M$71.22M-0.79120Gap Down
CTSO
Cytosorbents
2.1998 of 5 stars
$0.84
-1.2%
$5.50
+554.6%
-6.1%$52.61M$35.59M-2.33220

Related Companies and Tools


This page (NASDAQ:HCAQ) was last updated on 5/27/2025 by MarketBeat.com Staff
From Our Partners